Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Endocrinología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Open-label Phase II Multicenter Study Evaluating the Efficacy of Oral Everolimus Alone or in Combination With Pasireotide LAR i.m. in Advanced Progressive Pancreatic Neuroendocrine Tumors (PNET) - The COOPERATE-2 Study
INTERVENTIONAL
Inicio: 1 de jun de 2011
ID: NCT01374451
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo and Active-Controlled, 4-Arm, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy
INTERVENTIONAL
Inicio: 1 de may de 2010
ID: NCT01106677
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
INTERVENTIONAL
Inicio: 4 de sept de 2024
ID: NCT06528314
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of PHX1149T as Monotherapy in Subjects With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de jul de 2008
ID: NCT00690638
Completado
Fase 3
ClinicalTrials.gov
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de nov de 2008
ID: NCT00676338
Completado
Fase 3
ClinicalTrials.gov
Liraglutide Effect and Action in Diabetes (LEAD-1): Effect on Glycaemic Control After Once Daily Administration of Liraglutide in Combination With Glimepiride Versus Glimepiride Monotherapy Versus Glimepiride and Rosiglitazone Combination Therapy in Subjects With Type 2 Diabetes.
INTERVENTIONAL
Inicio: 1 de may de 2006
ID: NCT00318422
Completado
Fase 4
ClinicalTrials.gov
The Durability of Twice-Daily Insulin Lispro Low Mixture Compared to Once-Daily Insulin Glargine When Added to Existing Oral Therapy in Patients With Type 2 Diabetes and Inadequate Glycemic Control
INTERVENTIONAL
Inicio: 1 de dic de 2005
ID: NCT00279201
Completado
Fase 3
ClinicalTrials.gov
SELECT - Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity
INTERVENTIONAL
Inicio: 24 de oct de 2018
ID: NCT03574597
Activo, no recluta
ClinicalTrials.gov
A Randomised Phase III Trial of Adjuvant Radiation Therapy Versus Observation Following Breast Conserving Surgery and Endocrine Therapy in Patients With Molecularly Characterised Luminal A Early Breast Cancer
INTERVENTIONAL
Inicio: 21 de ago de 2017
ID: NCT02889874
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Active Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Muraglitazar (BMS-298585) Compared to Pioglitazone in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control
INTERVENTIONAL
Inicio: 1 de ago de 2005
ID: NCT00106808
Completado
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes PRONTO-T2D
INTERVENTIONAL
Inicio: 14 de jul de 2017
ID: NCT03214380
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Moderate-to-Severe Thyroid Eye Disease
INTERVENTIONAL
Inicio: 26 de oct de 2023
ID: NCT05987423
Reclutando
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase III Trial Evaluating Long-term Efficacy and Safety of Survodutide Weekly Injections in Adult Participants With Noncirrhotic Non-alcoholic Steatohepatitis/Metabolic Dysfunction-associated Steatohepatitis (NASH/MASH) and (F2) - (F3) Stage of Liver Fibrosis
INTERVENTIONAL
Inicio: 17 de sept de 2024
ID: NCT06632444
Reclutando
Fase 3
ClinicalTrials.gov
A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes
INTERVENTIONAL
Inicio: 15 de oct de 2025
ID: NCT07165028
Reclutando
Fase 3
ClinicalTrials.gov
A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Participants With Obesity or Overweight With and Without Type 2 Diabetes
INTERVENTIONAL
Inicio: 15 de may de 2025
ID: NCT06972459
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Randomized, Phase 2/3 Trial to Evaluate the Glycemic Efficacy, Renal Safety, Pharmacokinetics, and Pharmacodynamics of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment Who Have Inadequate Glycemic Control
INTERVENTIONAL
Inicio: 1 de jun de 2008
ID: NCT00663260
Completado
Fase 4
ClinicalTrials.gov
Comparison of the Hemodynamic Changes in Patients Under Treatment With Bisoprolol Versus Atenolol
INTERVENTIONAL
Inicio: 1 de feb de 2012
ID: NCT01939509
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
INTERVENTIONAL
Inicio: 12 de jul de 2017
ID: NCT03155997
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and Major Adverse Kidney Events in Participants With Body Mass Index ≥27 kg/m2 and Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease
INTERVENTIONAL
Inicio: 30 de abr de 2024
ID: NCT06383390
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3b Study to Investigate the Efficacy and Safety of Different Retatrutide Dose Escalation Schemes in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Controlled, Double-Blind Trial
INTERVENTIONAL
Inicio: 24 de ene de 2026
ID: NCT07357415
Anterior
1
...
16
17
18
...
434
Siguiente
Filtros